Choice of Nanovaccine Delivery Mode Has Profound Impacts on the Intralymph Node Spatiotemporal Distribution and Immunotherapy Efficacy
Overview
Authors
Affiliations
Nanovaccines have attracted booming interests in vaccinology studies, but the profound impacts of their delivery mode on immune response remain unrealized. Herein, immunostimulatory CpG-modified tumor-derived nanovesicles (CNVs) are used as a nanovaccine testbed to initially evaluate the impacts of three distinct delivery modes, including mono-pulse CNVs, staggered-pulse CNVs, and gel-confined CNVs. Fundamentally, delivery mode has enormous impacts on the immunomodulatory effects, altering the spatiotemporal distribution of nanovaccine residence and dendritic cell-T cell interaction in lymph nodes, and finally affecting subsequent T cell-mediated immune performance. As a result, the gel-confined delivery mode offers the best therapeutic performance in multiple tumor models. When extending evaluation to examine how the various delivery modes impact the performance of liposome-based nanovaccines, similar trends in intralymph node distribution and antitumor effect are observed. This work provides a strong empirical foundation that nanovaccine researchers should position delivery mode near the top of their considerations for the experimental design, which should speed up nanovaccine development and facilitate efficient selection of appropriate delivery modes in the clinic.
Jin S, Cho J, Gwak Y, Park S, Choi K, Choi J Adv Mater. 2024; 36(48):e2409914.
PMID: 39380383 PMC: 11602686. DOI: 10.1002/adma.202409914.
Advances in nano-immunotherapy for hematological malignancies.
Xu J, Liu W, Fan F, Zhang B, Sun C, Hu Y Exp Hematol Oncol. 2024; 13(1):57.
PMID: 38796455 PMC: 11128130. DOI: 10.1186/s40164-024-00525-3.
Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy.
He A, Li X, Dai Z, Li Q, Zhang Y, Ding M J Nanobiotechnology. 2023; 21(1):236.
PMID: 37482608 PMC: 10364424. DOI: 10.1186/s12951-023-01989-x.
Application of Nano-Delivery Systems in Lymph Nodes for Tumor Immunotherapy.
Xia Y, Fu S, Ma Q, Liu Y, Zhang N Nanomicro Lett. 2023; 15(1):145.
PMID: 37269391 PMC: 10239433. DOI: 10.1007/s40820-023-01125-2.
Yang Y, Wang N, Tian X, Wang X, Yang J, Leng X Int J Nanomedicine. 2022; 17:4791-4805.
PMID: 36246936 PMC: 9554921. DOI: 10.2147/IJN.S372048.